Post-Doctoral Fellow – Zhou Lab (Immune Engineering & Immunotherapy) jobs in United States
cer-icon
Apply on Employer Site
company-logo

The Wistar Institute · 1 month ago

Post-Doctoral Fellow – Zhou Lab (Immune Engineering & Immunotherapy)

The Wistar Institute is seeking a highly motivated Post-Doctoral Fellow to join Dr. Xiaoyu Zhou's lab, which focuses on immune engineering and cancer immunotherapy. The role involves developing innovative immunotherapies through research on immune communication and gene editing platforms.

BiotechnologyLife ScienceMedicalNon Profit
check
H1B Sponsor Likelynote

Responsibilities

Developing next-generation gene editing platforms to enable high-content functional genomics and therapeutic target discovery
Engineering synthetic and endogenous immune receptors to reprogram T cell function in solid tumors
Combining experimental and computational approaches to interrogate immune signaling networks

Qualification

CRISPR-based gene editingFunctional genomicsT cell engineeringImmune receptor biologyComputational data analysisCellular BiologyMolecular BiologyImmunologyGeneticsBioinformatics

Required

Ph.D. in Cellular or Molecular Biology, Immunology, Genetics, Bioinformatics, or a related field
Expertise in CRISPR-based gene editing and functional genomics
Expertise in T cell engineering and/or immune receptor biology
Expertise in computational or quantitative data analysis

Benefits

Excellent benefits package

Company

The Wistar Institute

twittertwittertwitter
company-logo
The Wistar Institute is a biomedical research institution that focuses on immunology, infectious diseases, and vaccine development.

H1B Sponsorship

The Wistar Institute has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (30)
2024 (19)
2023 (15)
2022 (22)
2021 (7)
2020 (6)

Funding

Current Stage
Growth Stage
Total Funding
$29.2M
Key Investors
William Penn FoundationNational Institutes of HealthNational Science Foundation
2025-11-24Grant· $0.6M
2025-08-19Grant· $17M
2024-05-14Grant· $0.65M

Leadership Team

leader-logo
Dario Altieri
President and Chief Executive Officer
linkedin
leader-logo
Joseph Trainor
Emeritus CFO
linkedin
Company data provided by crunchbase